Fujisawa Toshio 藤澤聡郎

… Alternative Names

FUJISAWA Toshio 藤澤聡郎

Less

Researcher Number	50627346
Other IDs
Affiliation (Current)	2025: 順天堂大学, 医学部, 先任准教授
Affiliation (based on the past Project Information) *help	2022 – 2024: 順天堂大学, 医学部, 先任准教授 2018 – 2021: 順天堂大学, 医学部, 准教授 2016: 順天堂大学, 医学部, 准教授 2013 – 2015: 東京医療保健大学, 医療保健学部, 講師
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 50010:Tumor biology-related / Gastroenterology
Keywords	Principal Investigator 神経浸潤 / 膵癌 / IL-13Rα2 / ポリフェノール / 転移 / 浸潤 / 膵臓癌 / Gemcitabine / EUS-FNA / エピジェネティクス … More / 疼痛緩和 / 上皮間葉転換 / IL-13receptorα2 / 抗癌剤抵抗性 / IL13Ra2 / 化学療法抵抗性 / 代謝経路 / 術前化学療法 / 超音波内視鏡 / EUS-FNB / HDAC inhibitor / Histone修飾 / IL-13 receptor alpha2 / epigenetics / 動物モデル / 浸潤転移 / 予測因子 / gemcitabine / 化学療法 / バイオマーカー / 抗癌剤効果予測 / 予後 / 浸潤・転移 / 緑茶ポリフェノール / IL-13Ra2 / 国際情報交換 / 転移抑制 / 国際情報交換(アメリカ) / IL13Ralpha2 / 予後規定因子 / 膵臓癌マウスモデル / HAT inhibitor / Epigallocatechin gallate / HAT阻害薬 / 生命予後 / IL-13Ralpha2 Less

Elucidation and Therapeutic Application of The Mechanism Promoting Neural Invasion by IL-13RA2 in Pancreatic CancerPrincipal Investigator
- Principal Investigator
  
  藤澤聡郎
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Juntendo University
Elucidation and clinical application of mechanism for chemotherapy resistance enhanced by IL-13Ralpha2 in pancreatic cancer.Principal Investigator
- Principal Investigator
  
  藤澤聡郎
- Project Period (FY)
  2021 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Juntendo University
An Efficacy of polyphenols for Il13Ra2-positive advanced pancreatic cancerPrincipal Investigator
- Principal Investigator
  
  FUJISAWA Toshio
- Project Period (FY)
  2018 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Juntendo University
Development of the new therapeutic approach targeting IL-13Ralpha2 in pancreatic ductal adenocarcinoma.Principal Investigator
- Principal Investigator
  
  Fujisawa Toshio
- Project Period (FY)
  2013 – 2016
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Juntendo University
  Tokyo Health Care University

All 2024 2023 2022 2021 2020 2016 2015

All Journal Article Presentation

[Journal Article] Dedicated Echoendoscope for Interventional Endoscopic Ultrasound: Comparison with a Conventional Echoendoscope2024
- Author(s)
  Fujisawa Toshio、Ishii Shigeto、Nakai Yousuke、Kogure Hirofumi、Tomishima Ko、Takasaki Yusuke、Ito Koichi、Takahashi Sho、Suzuki Akinori、Isayama Hiroyuki
- Journal Title
  
  Journal of Clinical Medicine
  
  Volume: 13 Issue: 10 Pages: 2840-2840
- DOI
  10.3390/jcm13102840
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07227
[Journal Article] STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancreatic cancer: an open label, phase I/IIa trial2023
- Author(s)
  Fujisawa Toshio、Tsuchiya Takayoshi、Kato Motohiko、Mizuide Masafumi、Takakura Kazuki、Nishimura Makoto、Kutsumi Hiromu、Matsuda Yoko、Arai Tomio、Ryozawa Shomei、Itoi Takao、Isayama Hiroyuki、Saya Hideyuki、Yahagi Naohisa
- Journal Title
  
  eClinicalMedicine
  
  Volume: 55 Pages: 101731-101731
- DOI
  10.1016/j.eclinm.2022.101731
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07227
[Journal Article] Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis2023
- Author(s)
  Takuji Okusaka, Masafumi Nakamura, Masahiro Yoshida, Masayuki Kitano, Yoshinori Ito, Nobumasa Mizuno, Keiji Hanada, Masato Ozaka, Chigusa Morizane, Yoshifumi Takeyama, Toshio Fujisawa et. al
- Journal Title
  
  International Journal of Clinical Oncology
  
  Volume: 28 Issue: 4 Pages: 493-511
- DOI
  10.1007/s10147-023-02317-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K07227, KAKENHI-PROJECT-18K07332, KAKENHI-PROJECT-19K08433
[Journal Article] Pancreatic Adenocarcinoma With Strong Expression of Interleukin-13 Receptor α2 Shows a Poor Response to Gemcitabine-Based Chemotherapy.2022
- Author(s)
  Tomishima K, Fujisawa T, Fukumura Y, Ushio M, Fukuma T, Takahashi S, Takasaki Y, Suzuki A, Ito K, Ishii S, Yao T, Nagahara A, Isayama H.
- Journal Title
  
  Pancreas
  
  Volume: 51 Issue: 9 Pages: 1133-1139
- DOI
  10.1097/mpa.0000000000002151
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06912, KAKENHI-PROJECT-21K07227, KAKENHI-PROJECT-18K07332
[Journal Article] IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer2021
- Author(s)
  Fujisawa T, Joshi BH, Takahashi S, Takasaki Y, Suzuki A, Ito K, Ochiai K, Tomishima K, Ishii S, Puri RK, Isayama H.
- Journal Title
  
  Diagnostics
  
  Volume: 11 Issue: 7 Pages: 1140-1140
- DOI
  10.3390/diagnostics11071140
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07332, KAKENHI-PROJECT-21K07227
[Journal Article] Immunotherapy for Pancreatic Cancer2020
- Author(s)
  Toshio Fujisawa, Hiroyuki Isayama
- Journal Title
  
  Juntendo Medical Journal
  
  Volume: 66 Issue: 3 Pages: 238-244
- DOI
  10.14789/jmj.2020.66.JMJ20-LN02
- NAID
  130007867030
- ISSN
  2187-9737, 2188-2126
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07332
[Journal Article] A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and Its Association With Poor Prognosis of Patients With Pancreatic Ductal Adenocarcinoma2020
- Author(s)
  Toshio Fujisawa, Takeshi Shimamura, Kaku Goto, Ryo Nakagawa, Ryosuke Muroyama, Yoshinori Ino, Hajime Horiuchi, Itaru Endo, Shin Maeda, Yasushi Harihara, Atsushi Nakajima,, Nobuyuki Matsuhashi, Naoya Kato, Hiroyuki Isayama, Ankit Puri, Akiko Suzuki, Ian Bellayr, Pamela Leland, Bharat H Joshi, Raj K Puri
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 5 Pages: 1294-1294
- DOI
  10.3390/cancers12051294
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07332
[Journal Article] Prophylactic Efficacy of 3- or 5-cm Pancreatic Stents for Preventing Post-ERCP Pancreatitis: A Prospective, Randomized Trial2016
- Author(s)
  Fujisawa T, Kagawa K, Ochiai K, Hisatomi K, Kubota K, Sato H, Nakajima A, Matsuhashi N.
- Journal Title
  
  Journal of Clinical Gastroenterology
  
  Volume: 50 Issue: 3 Pages: e30-e34
- DOI
  10.1097/mcg.0000000000000397
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25870846
[Journal Article] Obesity with Abundant Subcutaneous Adipose Tissue Increases the Risk of post-ERCP pancreatitis2016
- Author(s)
  Toshio Fujisawa, Koichi Kagawa, Kantaro Hisatomi, Kensuke Kubota, Hajime Sato, Atsushi Nakajima, Nobuyuki Matsuhashi
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: ePub first
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25870846
[Journal Article] Pancreatic paraganglioma with draining vessels2015
- Author(s)
  Misumi Y, Fujisawa T, Hashimoto H, Kagawa K, Noie T, Chiba H, Horiuchi H, Harihara Y, Matsuhashi N.
- Journal Title
  
  World Journal of Gastroenterology
  
  Volume: 21 Issue: 31 Pages: 9442-9447
- DOI
  10.3748/wjg.v21.i31.9442
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25870846
[Presentation] 膵癌抗癌剤治療におけるIL-13 receptorα2 発現による効果予測と感受性低下機序の解明2023
- Author(s)
  藤澤聡郎, 冨嶋享, 伊佐山浩通.
- Organizer
  第109回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-18K07332
[Presentation] 膵癌におけるIL-13 receptorα2発現とジェムシタビン感受性の関連性2023
- Author(s)
  藤澤　聡郎、冨嶋　享、伊佐山　浩通
- Organizer
  第109回日本消化器病学会総会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] 膵癌抗癌剤治療におけるIL-13 receptorα2 発現による効果予測と感受性低下機序の解明2023
- Author(s)
  藤澤聡郎, 冨嶋享, 伊佐山浩通.
- Organizer
  第109回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] Pancreatic Adenocarcinoma with Strong Expression of IL-13Rα2 Shows a Poor Response to Gemcitabine-based Chemotherapy2023
- Author(s)
  Ko Tomishima, Toshio Fujisawa, Yuki Fukumura, Hiroto Ota, Daishi Kabemura, Mako Ushio, Taito Fukuma, Sho Takahashi, Yusuke Takasaki, Akinori Suzuki, Koichi Ito, Shigeto Ishii, Takashi Yao, Hiroyuki Isayama
- Organizer
  United European Gastroenterology Week 2024
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] 膵癌化学療法効果予測におけるIL-13 receptor α2のバイオマーカーとしての役割2023
- Author(s)
  藤澤　聡郎、冨嶋　享、福村　由紀、齋浦　明夫、伊佐山　浩通
- Organizer
  第54回日本膵臓学会大会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] PANCREATIC ADENOCARCINOMA WITH STRONG EXPRESSION OF IL-13R?2 SHOWS A POOR RESPONSE TO GEMCITABINE-BASED CHEMOTHERAPY.2022
- Author(s)
  Ko Tomishima, Toshio Fujisawa, Hiroyuki Isayama
- Organizer
  United-European Gastrointestinal Week
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] 膵癌EUS-FNA検体で評価し得たIL-13 receptor&alpha2発現と化学療法効果について.2022
- Author(s)
  冨嶋享, 藤澤聡郎, 伊佐山浩通, 福村由紀
- Organizer
  第103回日本消化器内視鏡学会総会
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] 膵癌EUS-FNA検体で評価し得たIL-13 receptor a2発現と化学療法効果について2022
- Author(s)
  冨嶋　享、藤澤　聡郎、伊佐山　浩通、福村　由紀
- Organizer
  第103回　日本消化器内視鏡学会総会
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] PANCREATIC ADENOCARCINOMA WITH STRONG EXPRESSION OF IL-13RA2 SHOWS A POOR RESPONSE TO GEMCITABINE-BASED CHEMOTHERAPY.2022
- Author(s)
  Ko Tomishima, Toshio Fujisawa, Hiroyuki Isayama
- Organizer
  United-European Gastrointestinal Week
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07332
[Presentation] 膵癌EUS-FNA検体で評価し得たIL-13 receptor&alpha2発現と化学療法効果について.2022
- Author(s)
  冨嶋享, 藤澤聡郎, 伊佐山浩通, 福村由紀.
- Organizer
  第103回日本消化器内視鏡学会総会
- Data Source
  KAKENHI-PROJECT-18K07332
[Presentation] 膵癌の化学療法選択においてIL-13 receptorα2発現の示す意義.2022
- Author(s)
  冨嶋享, 藤澤聡郎, 伊佐山浩通
- Organizer
  U45消化器疾患イノベーションカンファレンス ~サイエンスでつながる次世代の会~
- Invited
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] 膵癌の化学療法の選択においてIL-13 receptor a2発現の示す意義2022
- Author(s)
  冨嶋　享、藤澤　聡郎、伊佐山　浩通
- Organizer
  第108回　日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] 癌精巣抗原IL-13Rα2の膵癌における役割と分子標的治療法の開発.2022
- Author(s)
  藤澤　聡郎
- Organizer
  第６回がんブレインストーミング研究会
- Invited
- Data Source
  KAKENHI-PROJECT-18K07332
[Presentation] 膵癌の化学療法の選択においてIL-13 receptor a2発現の示す意義2022
- Author(s)
  冨嶋　享、藤澤　聡郎、伊佐山　浩通
- Organizer
  第108回　日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-18K07332
[Presentation] 膵癌の化学療法選択においてIL-13 receptorα2発現の示す意義.2022
- Author(s)
  冨嶋享, 藤澤聡郎, 伊佐山浩通.
- Organizer
  第108回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-18K07332
[Presentation] 癌精巣抗原IL-13Rα2の膵癌における役割と分子標的治療法の開発2022
- Author(s)
  藤澤聡郎
- Organizer
  第６回がんブレインストーミング研究会
- Invited
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] 膵癌の化学療法選択においてIL-13 receptorα2発現の示す意義.2022
- Author(s)
  冨嶋享, 藤澤聡郎, 伊佐山浩通.
- Organizer
  第108回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-21K07227
[Presentation] 膵癌EUS-FNA検体で評価し得たIL-13 receptor a2発現と化学療法効果について2022
- Author(s)
  冨嶋　享、藤澤　聡郎、伊佐山　浩通、福村　由紀
- Organizer
  第103回　日本消化器内視鏡学会総会
- Data Source
  KAKENHI-PROJECT-18K07332
[Presentation] 膵臓癌におけるIL-13Ra2の予後規定因子と治療標的としての可能性2016
- Author(s)
  藤澤　聡郎, 中島　淳, 松橋　信行
- Organizer
  第102回日本消化器病学会総会
- Place of Presentation
  京王プラザホテル, 東京
- Year and Date
  2016-04-21
- Data Source
  KAKENHI-PROJECT-25870846
[Presentation] 膵臓癌におけるIL-13Ra2の予後規定因子と治療標的としての可能性2016
- Author(s)
  藤澤聡郎
- Organizer
  第１０２回日本消化器病学会総会
- Place of Presentation
  東京
- Year and Date
  2016-04-21
- Data Source
  KAKENHI-PROJECT-25870846
[Presentation] Overexpressed Interleukin-13 Receptor α2 Shorten Survival Time in Surgically Resected Pancreatic Cancer Patients2015
- Author(s)
  Toshio Fujisawa, Takeshi Shimamura, Joshi H. Bharat, Raj K. Puri
- Organizer
  Annual meeting of Society for Immunotherapy of Cancer
- Place of Presentation
  Maryland, USA
- Year and Date
  2015-11-05
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25870846

1. 伊佐山浩通 (70376458)

# of Collaborated Projects: 2 results

# of Collaborated Products: 20 results
2. 福村由紀 (90407312)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
3. NAKAJIMA Atsushi

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
4. PURI Raj, K

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results

Fujisawa Toshio 藤澤 聡郎

FUJISAWA Toshio 藤澤 聡郎

Research Projects

Research Products

Co-Researchers

Elucidation and Therapeutic Application of The Mechanism Promoting Neural Invasion by IL-13RA2 in Pancreatic CancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation and clinical application of mechanism for chemotherapy resistance enhanced by IL-13Ralpha2 in pancreatic cancer.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

An Efficacy of polyphenols for Il13Ra2-positive advanced pancreatic cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of the new therapeutic approach targeting IL-13Ralpha2 in pancreatic ductal adenocarcinoma.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Dedicated Echoendoscope for Interventional Endoscopic Ultrasound: Comparison with a Conventional Echoendoscope2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] STNM01, the RNA oligonucleotide targeting carbohydrate sulfotransferase 15, as second-line therapy for chemotherapy-refractory patients with unresectable pancreatic cancer: an open label, phase I/IIa trial2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Pancreatic Adenocarcinoma With Strong Expression of Interleukin-13 Receptor α2 Shows a Poor Response to Gemcitabine-Based Chemotherapy.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] IL-13Rα2 Is a Biomarker of Diagnosis and Therapeutic Response in Human Pancreatic Cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Immunotherapy for Pancreatic Cancer2020

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

[Journal Article] A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and Its Association With Poor Prognosis of Patients With Pancreatic Ductal Adenocarcinoma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prophylactic Efficacy of 3- or 5-cm Pancreatic Stents for Preventing Post-ERCP Pancreatitis: A Prospective, Randomized Trial2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Obesity with Abundant Subcutaneous Adipose Tissue Increases the Risk of post-ERCP pancreatitis2016

Author(s)

Journal Title

Data Source

[Journal Article] Pancreatic paraganglioma with draining vessels2015

Author(s)

Journal Title

DOI

Fujisawa Toshio 藤澤聡郎

FUJISAWA Toshio 藤澤聡郎